R, d. N. B., & JB, d. S. (2026). CorePAM: A 24-gene PAM50-derived expression score with cross-platform external validation for breast cancer prognosis. Breast cancer research : BCR, 28(1), . https://doi.org/10.1186/s13058-026-02298-5
Chicago Style (17th ed.) CitationR, de Negreiros Botan, and de Sousa JB. "CorePAM: A 24-gene PAM50-derived Expression Score with Cross-platform External Validation for Breast Cancer Prognosis." Breast Cancer Research : BCR 28, no. 1 (2026). https://doi.org/10.1186/s13058-026-02298-5.
MLA (9th ed.) CitationR, de Negreiros Botan, and de Sousa JB. "CorePAM: A 24-gene PAM50-derived Expression Score with Cross-platform External Validation for Breast Cancer Prognosis." Breast Cancer Research : BCR, vol. 28, no. 1, 2026, https://doi.org/10.1186/s13058-026-02298-5.